Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment

被引:167
作者
Bull, S. J.
Huezo-Diaz, P. [2 ]
Binder, E. B. [3 ]
Cubells, J. F. [3 ]
Ranjith, G. [4 ]
Maddock, C. [4 ]
Miyazaki, C. [4 ]
Alexander, N. [3 ]
Hotopf, M. [4 ]
Cleare, A. J. [5 ]
Norris, S. [6 ]
Cassidy, E. [7 ]
Aitchison, K. J. [2 ]
Miller, A. H. [3 ]
Pariante, C. M. [1 ]
机构
[1] Kings Coll London, Sect & Lab Stress Psychiat & Immunol, Div Psychol Med & Psychiat,James Black Ctr, Inst Psychiat,Ctr Cellular Basis Behav, London SE5 9NU, England
[2] Kings Coll London, Inst Psychiat, MRC, SGDP Ctr, London SE5 9NU, England
[3] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA
[4] Kings Coll London, Div Psychol Med & Psychiat, Inst Psychiat, Weston Educ Ctr, London SE5 9NU, England
[5] Kings Coll London, Div Psychol Med & Psychiat, Inst Psychiat, Sect Neurobiol Mood Disorders, London SE5 9NU, England
[6] St James Hosp, Dept Hepatol, Dublin, Ireland
[7] Cork Univ Hosp, Dept Psychiat, Cork, Ireland
基金
英国医学研究理事会;
关键词
interleukin-6; serotonin transporter; depressive symptoms; fatigue; cytokine; immunotherapy; CHRONIC HEPATITIS-C; VIRAL CLEARANCE; PROMOTER POLYMORPHISM; TRYPTOPHAN DEPLETION; IMMUNE ACTIVATION; SICKNESS BEHAVIOR; MAJOR DEPRESSION; CANCER-PATIENTS; PLUS RIBAVIRIN; ASSOCIATION;
D O I
10.1038/mp.2008.48
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Depression and fatigue are frequent side effects of interferon-alpha (IFN-alpha) treatment, and there is compelling evidence that the inflammatory response system (including interleukin-6, IL-6) and the serotonergic system is important in the pathophysiology of such symptoms. Functional polymorphisms in the promoter region of the IL-6 gene (rs1800795) and serotonin transporter gene (5-HTTLPR) have been identified as regulating these systems. The present study aimed to determine if these polymorphisms were associated with the development of depression and fatigue during IFN-alpha and ribavirin treatment. Ninety-eight Caucasian patients receiving pegylated IFN-alpha and ribavirin treatment for chronic hepatitis C virus at King's College Hospital, London, and Emory University Hospital, Atlanta, participated in this prospective cohort study. Symptoms of depression and fatigue were measured before treatment and at weeks 4, 8, 12 and 24 during treatment. The 'low IL-6' synthesizing genotype (CC) was associated with significantly fewer symptoms of depression (effect size = 0.7 at week 24; F = 9.4, d.f. = 436, P = 0.002). The 'high transcription' serotonin transporter (5-HTT) genotype (LL) was also associated with significantly fewer symptoms of depression, but with a much smaller effect (effect size = 0.2 at week 24; F = 4.5, d.f. = 436, P = 0.03). Neither polymorphisms were associated with symptoms of fatigue (IL-6: F = 1.2, d.f. = 430, P = 0.2; 5-HTT: F = 0.5, d.f. = 430, P = 0.5). The smaller effects of the 5-HTT polymorphism on depression may be explained by an interaction between the genes (F = 5.0, d.f. = 434, P = 0.02): the 'protective' effect of the 5-HTTLPR polymorphism was evident only in the presence of the 'low IL-6' genotype (F = 5.4, d.f. = 64, P = 0.02), not in the presence of the 'high IL-6' genotype (F = 2.2, d.f. = 369, P = 0.1). The association between the IL-6 polymorphism and reduced risk of depressive symptoms confirms the role of the inflammatory response system in the pathophysiology of IFN-alpha-induced depression; in contrast, the effect of the 5-HTT gene was small and perhaps dependent on the status of the inflammatory response. Molecular Psychiatry (2009) 14, 1095-1104; doi: 10.1038/mp.2008.48; published online 6 May 2008
引用
收藏
页码:1095 / 1104
页数:10
相关论文
共 65 条
[1]
A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior [J].
Anguelova, M ;
Benkelfat, C ;
Turecki, G .
MOLECULAR PSYCHIATRY, 2003, 8 (07) :646-653
[2]
The interleukin-6 -174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients [J].
Antonicelli, R ;
Olivieri, F ;
Bonafè, M ;
Cavallone, L ;
Spazzafumo, L ;
Marchegiani, F ;
Cardelli, M ;
Recanatini, A ;
Testarmata, P ;
Boemi, M ;
Parati, G ;
Franceschi, C .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 103 (03) :266-271
[3]
AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[4]
Serotonin transporter polymorphisms and persistent, pervasive childhood aggression [J].
Beitchman, Joseph H. ;
Baldassarra, Lidia ;
Mik, Helene ;
De Luca, Vincenzo ;
King, Nicole ;
Bender, Danielle ;
Ehtesham, Sahar ;
Kennedy, James L. .
AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (06) :1103-1105
[5]
C5b-9 and interleukin-6 in chronic hepatitis C -: Surrogate markers predicting short-term response to interferon alpha-2b [J].
Bíró, L ;
Varga, L ;
Pár, A ;
Nemesánszky, E ;
Telegdy, L ;
Ibrányi, E ;
Dávid, K ;
Horváth, G ;
Szentgyörgyi, L ;
Nagy, I ;
Dalmi, L ;
Abonyi, M ;
Füst, G ;
Horányi, M ;
Csepregi, A .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (10) :1092-1096
[6]
Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms [J].
Bonaccorso, S ;
Puzella, A ;
Marino, V ;
Pasquini, M ;
Biondi, M ;
Artini, M ;
Almerighi, C ;
Levrero, M ;
Egyed, B ;
Bosmans, E ;
Meltzer, HY ;
Maes, M .
PSYCHIATRY RESEARCH, 2001, 105 (1-2) :45-55
[7]
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy [J].
Capuron, L ;
Raison, CL ;
Musselman, DL ;
Lawson, DH ;
Nemeroff, CB ;
Miller, AH .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (07) :1342-1345
[8]
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy [J].
Capuron, L ;
Ravaud, A ;
Neveu, PJ ;
Miller, AH ;
Maes, M ;
Dantzer, R .
MOLECULAR PSYCHIATRY, 2002, 7 (05) :468-473
[9]
Neurobehavioral effects of interferon-α in cancer patients:: Phenomenology and paroxetine responsiveness of symptom dimensions [J].
Capuron, L ;
Gumnick, JF ;
Musselman, DL ;
Lawson, DH ;
Reemsnyder, A ;
Nemeroff, CB ;
Miller, AH .
NEUROPSYCHOPHARMACOLOGY, 2002, 26 (05) :643-652
[10]
Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state [J].
Capuron, L ;
Ravaud, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (17) :1370-1370